Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Anderson’s disease

Defects in the assembly or secretion of apoB-containing lipoproteins lead to the occurrence of familial hypobetalipoproteinemia (FHBL), abetalipoproteinemia (ABL), and Anderson s disease. [Pg.542]

In chylomicron retention disease (Anderson s disease) the secretory defect is restricted to intestinal apoB-containing lipoproteins (i.e., chylomicrons). This very rare recessively inherited disorder results from defects in a GTPase, Sarlb, which plays a critical role in the intracellular assembly and trafficking of chylomicrons. The affected patients present with fat malabsorption resulting in steatorrhea and deficiency of fat-soluble vitamins [46, 52, 54]. [Pg.543]

Canellos GP, Anderson JR, Propert KJ, et al. Chemotherapy of advanced Hodgkin s disease with MOPP, ABVD, or MOPP alternating with ABVD. New Engl J Med 1992 327 ... [Pg.1383]

Sands B, Anderson F, Bernstein C, Chey W, Fea-gan B, Fedorak R et al. Infliximab maintenance therapy for flstulizing Crohn s disease. N Engl J Med 2004 350(9) 876-85. [Pg.386]

Forsberg, G., Anderson, S. and Johnsson, L. 2000. Evaluation of hot, humid air seed treatment in thin layers and fluidized beds for seed pathogen sanitation. Journal of Plant Disease and Protection 109 357-370. [Pg.136]

Fabry s disease was described independently in 1898 by J. Fabry and W. Anderson. Characteristic symptoms are... [Pg.451]

Erkinjuntti T, Kurz A, Gauthier S et al. (2002). Efficacy of galanthamine in probable vascular dementia and Alzheimer s disease combined with cerebrovascular disease a randomised trial. Lancet 359 1283-1290 Feigin V, Ratnasabapathy Y, Anderson G (2005). Does blood pressure lowering treatment prevent dementia or cognitive decline in patients with cardiovascular and cerebrovascular disease Journal of Neurology Science 15 151-155... [Pg.377]

Mulle C, Choquet D, Korn H, Changeux JP (1992) Calcium influx through nicotinic receptor in rat central neurons its relevance to cellular regulation. Neuron 8 135-143 Nagele RG, D Andrea MR, Anderson WJ, Wang HY (2002) Intracellular accumulation of beta-amyloid(l-42) in neurons is facilitated by the alpha 7 nicotinic acetylcholine receptor in Alzheimer s disease. Neuroscience 110 199-211... [Pg.779]

Schellenberg GD, Bird TD, Wijsman EM, Oit HT, Anderson L, Nemeiis E, White JA, BormycastleL, Weber JL, Alonso ME, Potter H, Heston LL, Mardii GM (1992) Geiiedc linkage evidence for a familial Alzheimer s disease locus on chromosome 14. Science 258 668-671. [Pg.477]

Natli A, Hall E, Tuzova M, Dobbs M, Jons M, Anderson C, Woodward J, Guo Z, Eu W, Kryscio R, Wekslein D, Smith C, Markesbery WR, Mattson MP (2003) Autoandbodies to amyloid beta-pepdde (Abeta) are inaeased in Alriieimer s disease paderrts arrd Abeta andbodies can enliance Abeta neur otoxicity hnplicadorrs for disease pathogerr-esis and vaedne development. Neur omolecular Med 3 29—39. [Pg.639]

Gusella JF, Wexler NS, Conneally PM, Naylor SL, Anderson MA, Tanzi RE, Watkins PC, Ottina K, Wallace MR, Sakaguchi AY, Young AB, Shoulson I, Barilla E, Martin JB (1983) A polymorphic DNA marker, genetically linked to Huntington s disease. Nature 306 234-238. [Pg.399]

Anderson S, Rennke H, Brenner B.Therapeutic advantage ofconverting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 1986 77 1993-2000. [Pg.27]

Roberds SL, Anderson J, Basi G, et al. BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain implications for Alzheimer s disease therapeutics. Human Molec Genet. 2001 10(12) 1317-1324. [Pg.282]

Levy-Lahad E, Wijsman EM, Nemens E, Anderson L, Goddard AB, et al. 1995. A familial Alzheimer s disease locus on chromosome 1. Science 269 970-73... [Pg.578]

Owen, C. A., Jr., Copper metabolism and Wilson s disease. In Dynamic Clinical Studies with Radioisotopes (R. M. Kniseley, W. N. Tauxe, and E. B. Anderson, eds.), pp. 581-606. U. S. Atomic Energy Commission, Division of Technical Information, Oak Ridge, Tennessee, 1964. [Pg.61]

M.W. Sleeman, K.D. Anderson, P.D. Lambert, G.D. Yancopoulos, S.J. Wiegand Rediscovering good old friend IGF-I in the new millenium possible usefulness in Alzheimer s disease and stroke... [Pg.9]


See other pages where Anderson’s disease is mentioned: [Pg.397]    [Pg.527]    [Pg.41]    [Pg.397]    [Pg.527]    [Pg.41]    [Pg.459]    [Pg.255]    [Pg.277]    [Pg.344]    [Pg.479]    [Pg.125]    [Pg.622]    [Pg.732]    [Pg.742]    [Pg.749]    [Pg.816]    [Pg.642]    [Pg.394]    [Pg.394]    [Pg.44]    [Pg.167]    [Pg.51]    [Pg.246]    [Pg.29]    [Pg.199]   
See also in sourсe #XX -- [ Pg.542 , Pg.543 ]

See also in sourсe #XX -- [ Pg.1820 ]

See also in sourсe #XX -- [ Pg.527 ]




SEARCH



Anderson

© 2024 chempedia.info